Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls.

Patients with diabetes mellitus experience impaired wound healing, often resulting in chronic foot ulcers. Healing can be accelerated by application of growth factors like platelet-derived growth factor (PDGF). We investigated the mitogenic responses, measured by 3[H]thymidine incorporation, of fibroblasts cultured from diabetic ulcers, non-diabetic ulcers, and non-lesional diabetic and age-matched controls, to recombinant human PDGF-AB, epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I). We determined the optimal concentration of these factors and investigated which single factor, or combination of factors, added simultaneously or sequentially, induced the highest mitogenic response. For single growth factor additions, in all fibroblast populations significant differences in mitogenic response to different growth factors were observed, with PDGF-AB consistently inducing the highest response and IGF-I the lowest (p < 0.043). IGF-I produced only a 1.7-fold stimulation over control in diabetic ulcer fibroblasts, versus 2.95-fold for chronic ulcer, 3.2-fold for non-lesional (p = 0.007) and 5-fold for age-matched fibroblasts (p = 0.007). The highest mitogenic response induced by EGF was significantly less for chronic ulcer fibroblasts compared with age-matched and nonlesional controls (p < 0.03), chronic ulcer fibroblasts also needed significantly more EGF to reach this optimal stimulus (p < 0.02 versus age-matched and non-lesional controls). The simultaneous addition of FGF-IGF-I, PDGF-IGF-I and FGF-PDGF to diabetic ulcer fibroblasts always produced a higher stimulatory response than sequential additions (p < or = 0.05). Also the addition of bFGF, PDGF-AB and EGF prior to IGF-I induced a higher 3[H]thymidine uptake in all fibroblasts compared to the combination of each in reverse order. Significant differences were observed when comparing the combinations of growth factors with the highest stimulatory responses (PDGF-IGF-I, FGF-PDGF and EGF-PDGF added simultaneously) to a double dose of PDGF, with the highest mean rank for the combination PDGF-IGF-I (p = 0.018). In conclusion, combinations such as PDGF-AB and IGF-I may be more useful than PDGF-AB alone for application in chronic diabetic wounds.

[1]  E. Dabelsteen,et al.  Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. , 1999, The Journal of investigative dermatology.

[2]  J. Menzoian,et al.  Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. , 1997, Journal of vascular surgery.

[3]  R. Vracko,et al.  Restricted replicative life-span of diabetic fibroblasts in vitro: its relation to microangiopathy. , 1975, Federation proceedings.

[4]  M. Tershakowec Wound healing and the diabetic patient , 1980 .

[5]  A. Flyvbjerg Growth Factors and Diabetic Complications , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[6]  D. Rifkin,et al.  Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice , 1990, The Journal of experimental medicine.

[7]  U. Persson,et al.  Diabetic foot ulcers in a multidisciplinary setting An economic analysis of primary healing and healing with amputation , 1994, Journal of internal medicine.

[8]  Haralson Ma Extracellular matrix and growth factors: an integrated interplay controlling tissue repair and progression to disease. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[9]  D. Clemmons,et al.  Regulation of insulin‐like growth factor (IGF) binding protein‐2 synthesis and degradation by platelet‐derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells , 1995, Journal of cellular physiology.

[10]  E. Middelkoop,et al.  Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. , 1998, The Journal of investigative dermatology.

[11]  D. Greenhalgh,et al.  Synergistic actions of platelet‐derived growth factor and the insulin‐like growth factors in vivo , 1993, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[12]  J. R. Mekkes,et al.  Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation , 1999, Archives of Dermatological Research.

[13]  R. Colvin,et al.  Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  V. Falanga,et al.  Proliferation and collagen synthesis by human dermal fibroblasts cultured from different body sites. , 1991, Journal of dermatological science.

[15]  R. G. Allen,et al.  Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Reiber,et al.  Lower extremity foot ulcers and amputations in diabetes , 1995 .

[17]  B. Gilchrest,et al.  Growth factor responsiveness of cultured human fibroblasts declines with age. , 1983, Journal of gerontology.

[18]  G. Ryan,et al.  The effect of epidermal growth factor on wound healing in mice. , 1982, The Journal of surgical research.

[19]  D. Greenhalgh,et al.  PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. , 1994, The Journal of surgical research.

[20]  D. Brown,et al.  Effects of IGF-I and Glucose on Protein and Proteoglycan Synthesis by Human Fetal Mesangial Cells in Culture , 1991, Diabetes.

[21]  M S Reddy,et al.  The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. , 1991, Journal of periodontology.

[22]  R. Ross,et al.  Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. , 1987, The American journal of pathology.

[23]  B. Gilchrest,et al.  Effect of donor age on epidermal growth factor processing in man. , 1993, Experimental cell research.

[24]  J. Menzoian,et al.  Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. , 1998, Journal of vascular surgery.

[25]  S. Mohan,et al.  Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[27]  R. Colvin,et al.  Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. , 1989, The Journal of clinical investigation.

[28]  Rebeccah L. Brown,et al.  PDGF and TGF-α Act Synergistically to Improve Wound Healing in the Genetically Diabetic Mouse , 1994 .

[29]  D. Rowe,et al.  Abnormalities in Proliferation and Protein Synthesis in Skin Fibroblast Cultures from Patients with Diabetes Mellitus , 1977, Diabetes.

[30]  D. Steed Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. , 1995, Journal of vascular surgery.

[31]  D. Brenner,et al.  Insulin-like growth factor-I and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells. , 1995, Molecular endocrinology.

[32]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[33]  G. Schultz,et al.  Growth factors and wound healing: Part II. Role in normal and chronic wound healing. , 1993, American journal of surgery.